Helius Medical Technologies (HSDT) revenue breakdown
By product, Product is the largest at 77% of fiscal 2025 revenue; Other revenue grew fastest, 191% a year over 1 years.
By region, Canada is the largest at 62% of fiscal 2024 revenue, growing -20% a year over 2 years.
Revenue by product
Fiscal years, as Helius Medical Technologies reports them in its 10-K filings; fiscal 2025 total $548,000.
| Products | 2019 | 2020 | 2024 | 2025 | Share |
|---|---|---|---|---|---|
| Product | $1M | $625,000 | $476,000 | $420,000 | 77% |
| Other revenue | — | — | $44,000 | $128,000 | 23% |
| License | $5,000 | $27,000 | — | — | — |
| Franchise | $37,000 | $9,000 | — | — | — |
Revenue by region
Fiscal years, as Helius Medical Technologies reports them in its 10-K filings; fiscal 2024 total $476,000.
| Regions | 2022 | 2023 | 2024 | Share |
|---|---|---|---|---|
| Canada | $460,000 | $281,000 | $295,000 | 62% |
| United States | $318,000 | $324,000 | $181,000 | 38% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HSDT.
Open HSDT in InvestinglyQuestions
Where does Helius Medical Technologies make its money?
In fiscal 2025, by product: Product $420,000, Other revenue $128,000.
From Helius Medical Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.